WXW-12769-90019
3 vaccinations
2 coded responses
19 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 597 / MT
- Registered
- 2021-05-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-18
Registered in v-safe
-
2021-05-18
Dose 1 — Pfizer-BioNTech
-
2021-05-18
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-05-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-21
- 2021-05-23
- 2021-05-27
- 2021-06-01
-
2021-06-08
Dose 2 — Pfizer-BioNTech
- 2021-06-08
-
2021-06-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-06-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-06-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-06-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-06-15
Health check-in — day 7, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-06-25
Survey response — day 14, dose 2MedDRA: Heart rate increased — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Elevated heart rate (svt). Cause unknownMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-25
Report sent to call center — day 14, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-29
-
2021-06-29
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2021-07-06
- 2021-07-13
- 2021-07-21
- 2021-12-09
-
2021-12-22
Dose 3 — Pfizer-BioNTech
-
2022-06-24
Survey response — 6 months, dose 3MedDRA: Eyelid rash, Office visit, Rash — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Skin rash on eyelid and wrists · Healthcare visit (other): Specialist visitMedDRA releases: 2024-11 · check-in free text available
-
2022-06-24
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-06-27
- 2022-06-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-18 | Pfizer-BioNTech | |
| 2 | 2021-06-08 | Pfizer-BioNTech | |
| 3 | 2021-12-22 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-25 | Successful 2021-06-29 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-06-24 | Unsuccessful |
Free text
Release 9 — day 14, dose 2
Symptoms: Elevated heart rate (svt). Cause unknown
Release 12 — 6 months, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Eyelid rash | · | · | ✓ |
| SD | Heart rate increased | ✓ | ✓ | ✓ |
| SD | Rash | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release